# Docetaxel in Treating Patients With Stage IV Prostate Cancer

> **NCT00003781** · PHASE2 · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 25 (actual)

## Conditions studied

- Pain
- Prostate Cancer

## Interventions

- **DRUG:** docetaxel
- **PROCEDURE:** pain therapy
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00003781
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-12
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003781, "Docetaxel in Treating Patients With Stage IV Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*